Related Experiment Video
Updated: Aug 10, 2026

10:22
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
Published on: June 29, 2021
[Mechanisms of arbidole's immunomodulating action]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|May 1, 1999
Summary
Arbidole enhances the immune system, boosting interferon and phagocyte activity. This antiviral medication effectively treats influenza and respiratory infections with no observed side effects.
Area of Science:
- Immunology
- Virology
- Pharmacology
Background:
- Arbidole is known for its immunomodulating properties.
- Its effects on nonspecific defense factors require further elucidation.
- Understanding its therapeutic potential in viral infections is crucial.
Purpose of the Study:
- To investigate the immunomodulating activity of arbidole in vitro, in vivo, and in human subjects.
- To evaluate the efficacy of arbidole in preventing and treating influenza and other acute respiratory viral infections.
- To assess the safety and potential benefits of arbidole in specific patient populations and clinical settings.
Main Methods:
- Studies were conducted using cultured cells, animal models, and human clinical trials.
- Immunological parameters such as lymphocyte counts (CD4, CD8, B cells) and serum immunoglobulins were measured.
- Clinical outcomes including symptom severity, fever duration, and complication rates were assessed in patients with viral infections and chronic conditions.
Main Results:
- Arbidole demonstrated significant effects on nonspecific defense factors, including interferon induction and phagocyte activation.
- Patients treated with arbidole showed improved immunological parameters, particularly those with lower baseline immunity.
- Arbidole exhibited high preventive and therapeutic efficacy against influenza A and B, reducing intoxication, catarrhal syndrome, and fever duration. It also prevented post-influenza complications and reduced exacerbations of chronic diseases.
- The drug was beneficial for patients with secondary immunodeficiency, recurrent herpes, and chronic bronchitis, and improved postoperative immunological parameters in cardiac surgical patients.
- No adverse side effects were reported for arbidole across all study cohorts.
Conclusions:
- Arbidole possesses significant immunomodulating and broad-spectrum antiviral activities.
- It is effective in managing influenza and other acute respiratory viral infections, with a favorable safety profile.
- Arbidole shows promise for use in immunocompromised patients, those with chronic respiratory conditions, and in perioperative cardiac surgical care.
Related Concept Videos
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
